CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 369 (2) , 356-362
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81570156, 81770126, 81700161)
- Fujian Natural Science Foundation of China (2017J01354)
- Foundation of Health and Family Planning Commission in Fujian Province of China (2017-2-99)
- Xiamen Municipal Science and Technology Project (3502Z20164012)
This publication has 30 references indexed in Scilit:
- Aurora B and Kif2A control microtubule length for assembly of a functional central spindle during anaphaseJournal of Cell Biology, 2013
- Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancerJournal of Clinical Investigation, 2013
- Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic targetLeukemia, 2012
- Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell LymphomaJournal of Clinical Oncology, 2011
- An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphomaAnnals of Oncology, 2011
- Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCCBMC Cancer, 2010
- Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinaseProceedings of the National Academy of Sciences, 2010
- Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup StudyJournal of Clinical Oncology, 2010
- Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphomaAnnals of Oncology, 2008
- CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesisJournal of Cell Biology, 2001